Llwytho...
Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer’s disease
Cholinesterase inhibitors (ChE-Is) are among the main drugs approved for the treatment of Alzheimer’s disease (AD). Rivastigmine in the form of a transdermal patch is an alternative delivery method, and can give greater treatment compliance. Objectives: To conduct a preliminary assessment of the neu...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Dementia & Neuropsychologia |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Associação Neurologia Cognitiva e do Comportamento
2011
|
| Pynciau: | |
| Mynediad Ar-lein: | https://www.redalyc.org/articulo.oa?id=339529033012 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|